Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in various...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Knowledge is power': A framework for partnering with consumers in developing and delivering a scientific meeting in nephrology.

Nephrology (Carlton, Vic.)·2019
Same author

Closing the gap between evidence and practice in chronic kidney disease.

Kidney international supplements·2019
Same author

Action plan for optimizing the design of clinical trials in chronic kidney disease.

Kidney international supplements·2019
Same author

Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.

Nephrology (Carlton, Vic.)·2019
Same author

Patient-reported outcome measures for life participation in kidney transplantation: A systematic review.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2019
Same author

Improving the quality of healthcare: a cross-sectional study of the features of successful clinical networks.

Public health research & practice·2019

Related Experiment Video

Updated: May 30, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Topical steroid for chronic rhinosinusitis without polyps.

Kornkiat Snidvongs1, Larry Kalish, Raymond Sacks

  • 1Australian School of Advanced Medicine, Macquarie University, Sydney, NSW, Australia.

The Cochrane Database of Systematic Reviews
|August 12, 2011
PubMed
Summary
This summary is machine-generated.

Topical corticosteroids offer a benefit for chronic rhinosinusitis (CRS) without polyps, improving symptoms. Direct sinus delivery of steroids may enhance effectiveness, though more research is needed on optimal methods and duration.

More Related Videos

Intranasal Administration of CNS Therapeutics to Awake Mice
07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Published on: April 8, 2013

Related Experiment Videos

Last Updated: May 30, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Intranasal Administration of CNS Therapeutics to Awake Mice
07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Published on: April 8, 2013

Area of Science:

  • Otolaryngology
  • Pharmacology

Background:

  • Topical corticosteroids are a component of chronic rhinosinusitis (CRS) management without polyps.
  • Evidence for their overall benefit is limited, with varying delivery methods impacting efficacy.

Purpose of the Study:

  • To evaluate topical steroid efficacy in CRS patients without polyps.
  • To conduct a meta-analysis of symptom improvement, including subgroup analyses based on prior sinus surgery and delivery methods.

Main Methods:

  • A systematic search of multiple databases (PubMed, EMBASE, CENTRAL, etc.) was conducted up to July 2010.
  • Included randomized trials comparing topical corticosteroids to placebo, no treatment, or other topical steroids for CRS without polyps.
  • Data extraction and analysis were performed by two independent reviewers.

Main Results:

  • Ten studies (590 patients) met inclusion criteria, with low to medium risk of bias.
  • Topical steroids significantly improved sino-nasal symptoms compared to placebo (SMD -0.37, P=0.002) and increased responder rates (RR 1.69, P=0.002).
  • Direct sinus delivery showed greater benefit than simple nasal delivery (P=0.04); no significant differences were found for surgery status, quality of life, or adverse events.

Conclusions:

  • Topical corticosteroids are beneficial for CRS without polyps, with minor adverse effects.
  • Direct delivery to the sinuses may offer enhanced benefits.
  • Further research is needed on optimal delivery methods and treatment durations exceeding 12 weeks.